57.53
[]. Rodríguez G, et al. Hydrophilic polymer drug from a derivative of salicylic acid: synthesis, controlled release studies and biological behavior. Macromol Biosci. 004;4(6):579-586.
[]. F Boscá, et al. Photochemistry of -hydroxy-4-trifluoromethylbenzoic acid, major metabolite of the photosensitizing platelet antiaggregant drug triflusal. Photochem Photobiol. 00 May;73(5):463-8.
[3]. Hae Won Lee, et al. A phase I study to characterize the multiple-dose pharmacokinetics, pharmacodynamics and safety of new enteric-coated triflusal formulations in healthy male volunteers. Expert Opin Drug Metab Toxicol. 0 Dec;7():47-9.
[4]. Hea-Young Cho, et al. Simultaneous determination of triflusal and its major active metabolite, -hydroxy-4-trifluoromethyl benzoic acid, in rat and human plasma by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 003 Dec 5;798():57-64.
[5]. J Ramis, et al. Pharmacokinetics of triflusal after single and repeated doses in man. Int J Clin Pharmacol Ther Toxicol. 990 Aug;8(8):344-9.
H30-H35-H38-H4
P64-P70-P73-P80-P30+P35-P330-P36+P364-P405-P50
6.
8